Janux Therapeutics, Inc. (JANX) vs Savara Inc. (SVRA)
Janux Therapeutics, Inc. and Savara Inc. are both Biotechnology companies. Janux Therapeutics, Inc. and Savara Inc. are of similar size ($1.0B and $1.0B). Savara Inc. has the higher net margin (0.00% vs −427.5%) and the lower return on invested capital (−12,213.2% vs 0.00%). Across the 14 metrics below, Janux Therapeutics, Inc. leads on 9 and Savara Inc. on 5.
Valuation
Profitability
| Metric | JANX | SVRA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (598.15%) | 0.00% | 0.00% |
| Net margin | (427.47%) | 0.00% | 0.00% |
| Free cash flow margin | (174.69%) | 0.00% | 0.00% |
| Return on equity | (10.70%) | (105.48%) | (57.72%) |
| Return on assets | (10.06%) | (78.28%) | (49.22%) |
| Return on invested capital | 0.00% | (12,213.18%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack